| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32795910P | 2010-04-26 | 2010-04-26 | |
| US32796310P | 2010-04-26 | 2010-04-26 | |
| US32796810P | 2010-04-26 | 2010-04-26 | |
| EP10161034 | 2010-04-26 | ||
| EP10161034 | 2010-04-26 | ||
| EP10161032 | 2010-04-26 | ||
| EP10161032 | 2010-04-26 | ||
| US327968P | 2010-04-26 | ||
| EP10161029 | 2010-04-26 | ||
| EP10161029 | 2010-04-26 | ||
| US327959P | 2010-04-26 | ||
| US327963P | 2010-04-26 | ||
| US201061424411P | 2010-12-17 | 2010-12-17 | |
| US201061424407P | 2010-12-17 | 2010-12-17 | |
| US201061424402P | 2010-12-17 | 2010-12-17 | |
| EP10195764 | 2010-12-17 | ||
| EP10195760 | 2010-12-17 | ||
| EP10195766 | 2010-12-17 | ||
| EP10195766 | 2010-12-17 | ||
| EP10195764 | 2010-12-17 | ||
| EP10195760 | 2010-12-17 | ||
| US424411P | 2010-12-17 | ||
| US424402P | 2010-12-17 | ||
| US424407P | 2010-12-17 | ||
| PCT/EP2011/056548WO2011134944A2 (en) | 2010-04-26 | 2011-04-26 | Low-oil pharmaceutical emulsion compositions comprising progestogen |
| Publication Number | Publication Date |
|---|---|
| ES2531646T3true ES2531646T3 (es) | 2015-03-18 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES14176970.3TActiveES2576190T3 (es) | 2010-04-26 | 2011-04-26 | Composiciones farmacéuticas de emulsión que comprenden progestógeno |
| ES14196653.1TActiveES2606585T3 (es) | 2010-04-26 | 2011-04-26 | Composiciones de emulsión farmacéuticas con bajo contenido de aceite que comprenden progestágeno |
| ES11717561.2TActiveES2531646T3 (es) | 2010-04-26 | 2011-04-26 | Composiciones de emulsión farmacéuticas con bajo contenido de aceite que comprenden progestágeno |
| ES11716893.0TActiveES2514690T3 (es) | 2010-04-26 | 2011-04-26 | Composiciones farmacéuticas de emulsión que comprenden progestógeno |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES14176970.3TActiveES2576190T3 (es) | 2010-04-26 | 2011-04-26 | Composiciones farmacéuticas de emulsión que comprenden progestógeno |
| ES14196653.1TActiveES2606585T3 (es) | 2010-04-26 | 2011-04-26 | Composiciones de emulsión farmacéuticas con bajo contenido de aceite que comprenden progestágeno |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES11716893.0TActiveES2514690T3 (es) | 2010-04-26 | 2011-04-26 | Composiciones farmacéuticas de emulsión que comprenden progestógeno |
| Country | Link |
|---|---|
| US (4) | US8476252B2 (es) |
| EP (4) | EP2857042B1 (es) |
| JP (1) | JP5886273B2 (es) |
| KR (1) | KR101822680B1 (es) |
| CN (2) | CN102946865B (es) |
| AR (1) | AR081542A1 (es) |
| AU (1) | AU2011246527B2 (es) |
| BR (1) | BR112012027279B1 (es) |
| CA (2) | CA2797253C (es) |
| EA (1) | EA022460B1 (es) |
| ES (4) | ES2576190T3 (es) |
| GE (1) | GEP20166457B (es) |
| HK (1) | HK1181998A1 (es) |
| IL (2) | IL222710A (es) |
| MX (1) | MX2012012491A (es) |
| MY (1) | MY156858A (es) |
| NZ (1) | NZ603176A (es) |
| PH (1) | PH12012502120B1 (es) |
| PL (1) | PL2563335T3 (es) |
| PT (1) | PT2563335E (es) |
| SG (1) | SG185025A1 (es) |
| TW (1) | TW201138782A (es) |
| WO (2) | WO2011134937A2 (es) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201138782A (en) | 2010-04-26 | 2011-11-16 | Besins Healthcare Lu Sarl | Low-oil pharmaceutical emulsion compositions comprising progestogen |
| WO2013078422A2 (en) | 2011-11-23 | 2013-05-30 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| IN2014DN08088A (es)* | 2012-02-29 | 2015-05-01 | Braun Melsungen Ag | |
| TWI651098B (zh)* | 2012-02-29 | 2019-02-21 | Ｂ 柏藍麥桑根公司 | 含荷爾蒙的乳劑 |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
| US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
| US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| EP2968140A4 (en)* | 2013-03-15 | 2016-11-16 | Pharmagenesis Inc | INTRAVENOUS EMULSIONS OF TRIPTOLIDE AS IMMUNOMODULATORS AND ANTICROBIAL I |
| WO2015077717A1 (en) | 2013-11-25 | 2015-05-28 | The Broad Institute Inc. | Compositions and methods for diagnosing, evaluating and treating cancer by means of the dna methylation status |
| WO2015085147A1 (en) | 2013-12-05 | 2015-06-11 | The Broad Institute Inc. | Polymorphic gene typing and somatic change detection using sequencing data |
| US20160310584A1 (en)* | 2013-12-06 | 2016-10-27 | The Broad Institute Inc. | Formulations for neoplasia vaccines |
| WO2015095811A2 (en) | 2013-12-20 | 2015-06-25 | The Board Institute Inc. | Combination therapy with neoantigen vaccine |
| AU2015264003A1 (en) | 2014-05-22 | 2016-11-17 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US10098894B2 (en) | 2014-07-29 | 2018-10-16 | Therapeuticsmd, Inc. | Transdermal cream |
| EP3234130B1 (en) | 2014-12-19 | 2020-11-25 | The Broad Institute, Inc. | Methods for profiling the t-cell- receptor repertoire |
| US10975442B2 (en) | 2014-12-19 | 2021-04-13 | Massachusetts Institute Of Technology | Molecular biomarkers for cancer immunotherapy |
| CA2971786A1 (en)* | 2015-03-31 | 2016-10-06 | Fresenius Kabi Deutschland Gmbh | Emulsions for parenteral administration |
| BR112017024797A2 (pt) | 2015-05-20 | 2018-08-07 | The Broad Institute Inc. | neoantígenos partilhados |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| WO2017173044A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd Inc. | Steroid hormone compositions in medium chain oils |
| EP3435977A4 (en) | 2016-04-01 | 2019-10-16 | Therapeuticsmd, Inc. | PHARMACEUTICAL COMPOSITION OF STEROID HORMONE |
| CN106074383B (zh)* | 2016-07-27 | 2019-03-08 | 武汉科福新药有限责任公司 | 孕激素药物脂微球注射液及其制备方法 |
| US20180207097A1 (en)* | 2017-01-23 | 2018-07-26 | Government Of The United States As Represented By The Secretary Of The Air Force | Non-toxic vehicle to solubilize, deliver, and obtain biological activity of steroid hormones at cell, tissue, and organ targets, in vitro and in vivo |
| EP3574116A1 (en) | 2017-01-24 | 2019-12-04 | The Broad Institute, Inc. | Compositions and methods for detecting a mutant variant of a polynucleotide |
| KR20210102936A (ko)* | 2018-12-10 | 2021-08-20 | 헤일로 사이언스 엘엘씨 | 안정적인 마취제 제제 및 관련 복용량 형태 |
| US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
| EP3878434A1 (en)* | 2020-03-12 | 2021-09-15 | Lipoid GmbH | Sunflower phospholipid composition containing phosphatidylcholine |
| US20230098327A1 (en)* | 2021-08-30 | 2023-03-30 | Premier Nutrition Company, Llc | Sleep-inducing beverage composition, its method of production and the method of use |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60258110A (ja) | 1984-06-05 | 1985-12-20 | Daigo Eiyou Kagaku Kk | 静脈注射可能なプロゲステロン乳化注射液 |
| US5364632A (en)* | 1989-04-05 | 1994-11-15 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Medicinal emulsions |
| IL89856A (en) | 1989-04-05 | 1993-05-13 | Yissum Res Dev Co | Medical emulsions for liphophilic drugs containing a medium-chain triglyceride oil as a carrier |
| SE9301171D0 (sv)* | 1993-04-07 | 1993-04-07 | Ab Astra | Pharmaceutical composition containing lipophilic drugs |
| SE9403389D0 (sv) | 1994-10-06 | 1994-10-06 | Astra Ab | Pharmaceutical composition containing derivattves of sex hormones |
| HUP0202235A3 (en) | 1999-07-22 | 2004-05-28 | Aventis Pharmaceuticals Inc Br | Preserved pharmaceutical formulations |
| US6720001B2 (en)* | 1999-10-18 | 2004-04-13 | Lipocine, Inc. | Emulsion compositions for polyfunctional active ingredients |
| US6327968B1 (en) | 2000-03-17 | 2001-12-11 | Pizza Hut, Inc. | System and method for producing par-baked pizza crusts |
| EP1488785A1 (de) | 2003-06-18 | 2004-12-22 | B. Braun Melsungen Ag | Ölemulsion zur postnatalen Hormonsubstitution |
| WO2005105040A2 (en) | 2004-04-26 | 2005-11-10 | Micelle Products, Inc. | Water-soluble formulations of fat soluble vitamins and pharmaceutical agents and their applications |
| EP1611879B1 (en) | 2004-07-02 | 2009-08-12 | Novagali Pharma SA | Use of emulsions for intra- and periocular injection |
| US7473687B2 (en) | 2005-03-24 | 2009-01-06 | Emory University | Methods for the treatment of a traumatic central nervous system injury |
| EP2431042B1 (en) | 2005-03-24 | 2013-06-26 | Emory University | Methods for the treatment of central nervous system injury via a tapered administration protocol |
| EP2001438A2 (en)* | 2006-02-09 | 2008-12-17 | Macusight, Inc. | Stable formulations, and methods of their preparation and use |
| CN101152186B (zh)* | 2007-09-05 | 2011-07-06 | 杭州平和安康医药科技有限公司 | 黄体酮注射液及其制备方法 |
| TW201138782A (en) | 2010-04-26 | 2011-11-16 | Besins Healthcare Lu Sarl | Low-oil pharmaceutical emulsion compositions comprising progestogen |
| Publication | Publication Date | Title |
|---|---|---|
| ES2531646T3 (es) | Composiciones de emulsión farmacéuticas con bajo contenido de aceite que comprenden progestágeno | |
| ES2478264T3 (es) | Glicerosomas y uso de estos en preparaciones farmacéuticas y cosméticas para aplicación tópica | |
| CL2017000829A1 (es) | Formulación farmacéutica que comprende mezcla de anticuerpo anti-alfa4beta7, un agente tamponante, y citrato; uso de dicha formulación para tratar enfermedad inflamatoria del intestino. | |
| CL2015001984A1 (es) | (divisional de la sol. 1567-2013) combinaciones de principios activos que comprenden piridiletilbenzamidas y otros principios activos. | |
| PH12016500100B1 (en) | Self-emulsifying composition of omega3 fatty acid | |
| BR112017008660A2 (pt) | formulação de solução de proteína estável contendo alta concentração de um anticorpo anti-vegf | |
| BR112018003877A2 (pt) | “composição farmacêutica, método para reduzir a gordura subcutânea, método para a redução de peso corporal e uso de uma composição farmacêutica” | |
| BRPI0615292A8 (pt) | composições e métodos para preparação de fármacos de má solubilidade em água com estabilidade aumentada | |
| AR077338A1 (es) | Formulacion farmaceutica. procedimiento de preparacion. disolucion para perfusion. | |
| AR088381A1 (es) | Formulaciones de etanercept estabilizadas con meglumina | |
| PA8854101A1 (es) | Derivados de imidazol bicíclicos sustituidos como moduladores de gamma secretasa | |
| BR112015008186A2 (pt) | formulação de um anticorpo estável e de baixa viscosidade | |
| RU2020108079A (ru) | Инъекционная фармацевтическая композиция, содержащая мелоксикам, и способ ее получения | |
| PE20200404A1 (es) | Composicion farmaceutica de clorhidrato de s-ketamina | |
| BR112013003581A2 (pt) | formulação farmacêutica ou nutracêutica gastro resistente que compreende um ou mais sais do ácido algínico | |
| BR112013008601A8 (pt) | Formulações de emulsão de clevidipina contendo agentes antimicrobianos | |
| IN2014MN02213A (es) | ||
| CY1110037T1 (el) | Σκευασματα για βενζιμιδαζολυλ πυριδυλ αιθερες | |
| EP4233838A3 (en) | Pharmaceutical formulations containing corticosteroids for topical administration | |
| BRPI0922806B8 (pt) | composição farmacêutica oral compreendendo bendamustina | |
| JO3587B1 (ar) | أشكال جرعات بينداموستين عن طريق الفم | |
| BR112013010714A2 (pt) | Composição farmacêutica e uso de um composto antibiótico | |
| BR112015001627A2 (pt) | composição farmacêutica, respectivos usos e método para diminuir a frequência de micção | |
| AR086491A1 (es) | Composicion farmaceutica que comprende fexofenadina | |
| BR112016009214A8 (pt) | uso de um composto para preparação de um medicamento para o tratamento de distrofia muscular e composição farmacêutica |